When psychedelic treatment or a clinical trial ends, the protocol stops. The person’s experience may not.
So where should responsibility end, and what should continuity of support look like afterward?
#LivedExperience #PsychedelicResearch #PsychedelicTherapy #PatientSafety
When psychedelic treatment or a clinical trial ends, the protocol stops. The person’s experience may not. So where should responsibility end, and what should continuity of support look like afterward? #LivedExperience #PsychedelicResearch #PsychedelicTherapy #PatientSafety
0 vue
Publié le 02/11/2026 17:26
0:51
When psychedelic treatment or a clinical trial ends, the protocol stops. The person’s experience may not.
So where should responsibility end, and what should continuity of support look like afterward?
#LivedExperience #PsychedelicResearch #PsychedelicTherapy #PatientSafety
2 commentaires
?
One of those questions that sounds simple until you’ve actually lived through the transition out of a clinical trial or treatment. The structure can disappear before you’ve really figured out what support you need or what comes next.
The end of treatment is often treated like a clean endpoint but for the person going through it, it may not always be so clean.